Arkolith/Insider Trading/HOWL/Form 4

UBS Oncology Impact Fund L.P.

10% OwnerWerewolf Therapeutics, Inc. (HOWL) · full profile →Form 4 · filed Dec 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$137K
Net Open-Market Flow
-$137K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2025Sell(S)61K$0.94$57K5.0M
Nov 28, 2025Sell(S)20K$0.99$20K5.0M
Nov 26, 2025Sell(S)61K$0.98$60K5.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000564) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML